title: Advances in the treatment of melanoma.
authors.affiliation: NIHR Biomedical Research Centre at Guy's and St Thomas's Hospitals and King's College London. katie.lacy@kcl.ac.uk
authors.forename: Katie E
authors.initials: KE
authors.lastname: Lacy
authors.forename: Sophia N
authors.initials: SN
authors.lastname: Karagiannis
authors.forename: Frank O
authors.initials: FO
authors.lastname: Nestle
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D015551:Autoimmunity / Q000187:drug effects*; D019468:Disease Management; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D000074324:Ipilimumab; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy; D013449:Sulfonamides / Q000627:therapeutic use*; D035703:Therapies, Investigational; D000077484:Vemurafenib
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D007211:Indoles; D000074324:Ipilimumab; D013449:Sulfonamides; D000077484:Vemurafenib